Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)BNT162b2 mRNA SARS-CoV-2 백신의 추가 용량을 2회 백신 용량 후 적절한 체액 반응 없이 신장 이식 수용자에게 투여할 때 면역 억제 감소: 무작위 대조 시험 프로토콜(BECAME 연구)Article Published on 2021-10-112022-09-11 Journal: BMJ Open [Category] SARS, 임상, [키워드] All participant All participants Antibody Response antimetabolite approved BNT162b2 BNT162b2 mRNA BNT162b2 vaccine booster dose calculated consequence control group COVID-19 described dose eligible Endpoint Ethics humoral immunology Immunosuppression immunosuppressive Inadequate intervention group investigator-initiated kidney transplant recipient kidney transplant recipients Local local Ethics Committee mRNA observational study Open-label participant Patient patients Primary outcome prospective observational study protocol Rabin Medical Center randomised controlled randomised controlled trial receive recipients reduction regimen registration number renal Renal transplantation required Result Sample size SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine Seropositivity solid organ solid organ transplant submitted T-cell Response tested Trial Vaccination strategy Vaccine vaccine dose written Informed Consent [DOI] 10.1136/bmjopen-2021-055611 PMC 바로가기 [Article Type] Article
The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?Review Published on 2021-10-052022-10-28 Journal: Viruses [Category] COVID-19, MERS, SARS, [키워드] adverse effect available data Breastfeeding Care Characteristics clinical manifestation Complication complications Course COVID-19 Critical current database delivery developmental head Health involved Neonatal neonatal health outbreak pandemic plethora poor quality Pregnancy pregnant patient reported Research risk SARS-CoV-2 Transmission vaccination Vaccination strategy Viral transmission Volume was performed [DOI] 10.3390/v13102000 PMC 바로가기 [Article Type] Review
Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve WeeksArticle Published on 2021-10-042022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] age anti-S1 IgG antibody Anti-spike antibody binding BNT162b2 booster booster vaccination caused COVID-19 COVID-19 vaccination demonstrated dialysis Follow-up healthy control healthy controls Hemodialysis homologous Humoral response individual IQR longitudinal median mounted multicenter neutralization neutralizing antibody Patient patients Peritoneal dialysis reduced required response SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike second vaccination Seroconversion significantly susceptible vaccination Vaccination strategies Vaccination strategy vaccine-induced antibody variants of concern Week [DOI] 10.3390/vaccines9101130 PMC 바로가기 [Article Type] Article
2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?Article Published on 2021-10-012023-06-14 Journal: Acta bio-medica : Atenei Parmensis [Category] MERS, SARS, [키워드] HCW vaccination influenza vaccine Vaccination strategy [DOI] 10.23750/abm.v92iS6.12230 PMC 바로가기
Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics바이러스 레드 퀸 역학 단계에서 SARS-CoV-2의 면역 반응 및 백신 접종 전략의 관련성Article Published on 2021-10-012022-09-11 Journal: Indian journal of medical microbiology [Category] SARS, 변종, [키워드] Analysis Antibody Response approved B.1.617 B.1.617.2 circulating circulating variant coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccines delta variant dominant driving effective Effectiveness Efficacy elicit expressed Factor First wave genetic variants Healthcare system herd immunity immune response Immunity immunogenicity India indicate majority memory B cell memory B cells Mild Mutation NAb NAb titer pandemic Phylogenetic analysis population immunity pre-fusion raised Relevance SARS-CoV-2 SARS-CoV-2 isolate SARS-CoV-2 isolates SARS-CoV-2 variant SARS-CoV-2 variants second wave Spread T cell T cells trajectory Transmissibility Vaccination strategy Vaccine vaccine efficacy vaccine-induced immune response Vaccine-induced immunity variant variants variants of concern virus virus variant virus variants VoC [DOI] 10.1016/j.ijmmb.2021.08.001 PMC 바로가기 [Article Type] Article
New variants of SARS-CoV-2SARS-CoV-2의 새로운 변종Review Published on 2021-10-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] SARS, 변종, 치료기술, 치료제, [키워드] African B.1.1.7 B.1.351 B.1.427 B.1.429 B.1.617 characterization consequence containment measures country COVID-19 dispersion English epidemiological Evolution excluded expected Immunity India individuals infected individuals Infection Laboratory mayor measure New number of infected P.1 produced public health SARS-CoV-2 SARS-CoV2 South Spanish Spread Transmissibility Vaccination strategies Vaccination strategy Vaccine vaccine resistance Vaccines variant variants variants of interest variants of SARS-CoV-2 Viral variants virus Whole genome sequencing [DOI] 10.37201/req/071.2021 PMC 바로가기 [Article Type] Review
Coronavirus Disease 2019 on the Heels of Ebola Virus Disease in West AfricaArticle Published on 2021-10-012022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] addition African calibrated can be used category compartmental model coronavirus disease 2019 (COVID-19) pandemic country COVID-19 COVID-19 infection COVID-19 pandemic death deaths Decision making develop disease Ebola Ebola outbreak Ebola virus disease Effect Effectiveness heel highlight Increased increases in Infection information International Intervention Isolation lesson Liberia Multiple National non-pharmaceutical interventions (NPIs) NPI NPIs pandemic predict reported resource SEIR Simulation susceptible susceptible–exposed–infected–recovered (SEIR) models targeted intervention Treatment vaccination Vaccination strategy Vaccinations Vaccine was used West while [DOI] 10.3390/pathogens10101266 PMC 바로가기 [Article Type] Article
Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 InfectionSARS-CoV-2 감염 후 외래 환자의 체액 및 세포 면역 반응의 장기 경과Public Health Published on 2021-09-272022-09-11 Journal: Frontiers in Public Health [Category] MERS, SARS, 진단, 치료기술, [키워드] acquired B acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody anti-SARS-CoV-2 immunoglobulin antibody borderline characterization circulating circulating antibody Concentration conducted coronavirus Course COVID-19 COVID-19 disease COVID-19 recovered patient cross-sectional analysis enrolled IFN-γ IgG IgG antibodies IgG antibody IGRA immune response immune responses Immunity Immunoglobulin Immunoglobulin G immunological reaction individual Infection interferon Interferon-gamma interferon-gamma release assay majority marker Mild moderate disease natural infection Neutralizing antibodies neutralizing antibody Outpatient Patient patients Peripheral blood peripheral blood cell peripheral blood cells positive public health respiratory response robust S-protein SARS-CoV-2 Seroprevalence severe acute respiratory syndrome Coronavirus study visit subject sustained T cell titre Vaccination strategies Vaccination strategy [DOI] 10.3389/fpubh.2021.732787 PMC 바로가기 [Article Type] Public Health
Mapping of the Covid-19 Vaccine Uptake Determinants From Mining Twitter DataScience - General Published on 2021-09-242022-10-30 Journal: Ieee Access [Category] COVID-19, [키워드] 6As taxonomy Characteristics Coverage COVID-19 determinant determinants of vaccine uptake Effectiveness Efficacy Factors Immunity immunization immunization hesitancy mapping National opinion Research SARS-CoV-2 Side effects the vaccine uptake vaccination Vaccination strategy Vaccine Vaccine acceptance Vaccine hesitancy [DOI] 10.1109/ACCESS.2021.3115554 PMC 바로가기 [Article Type] Science - General
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future ScenariosReview Published on 2021-09-232022-10-31 Journal: Cancers [Category] COVID-19, [키워드] accounted acute respiratory syndrome Cancer challenge China chronic Clinical management Complication coronavirus COVID-19 COVID-19 infection COVID-19 pandemic Efficacy Future Hematological malignancies Hemorrhagic high risk immunosuppressive increased risk Infection information interferon investigated knowledge management MPNs mRNA vaccine myelofibrosis myeloproliferative neoplasm outbreak outcome pandemic Patient Prognosis provided receive reported risk ruxolitinib SARS-CoV2 scenario severe COVID-19 severity of COVID-19 simple syndrome therapy thrombotic thrombotic risk Vaccination strategy Vaccine [DOI] 10.3390/cancers13194750 PMC 바로가기 [Article Type] Review